NGM BIOPHARMACEUTICALS INC Quarterly Current Ratio in % from Q3 2019 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ngm Biopharmaceuticals Inc quarterly Current Ratio history and growth rate from Q3 2019 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Current Ratio for the quarter ending December 31, 2023 was 718 %, a 4.45% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 718 +30.6 +4.45% Dec 31, 2023
Q3 2023 669 -17.2 -2.5% Sep 30, 2023
Q2 2023 646 -48.3 -6.96% Jun 30, 2023
Q1 2023 659 -67.2 -9.26% Mar 31, 2023
Q4 2022 687 -97.6 -12.4% Dec 31, 2022
Q3 2022 686 -140 -17% Sep 30, 2022
Q2 2022 694 -175 -20.1% Jun 30, 2022
Q1 2022 726 -154 -17.5% Mar 31, 2022
Q4 2021 785 -108 -12.1% Dec 31, 2021
Q3 2021 826 -119 -12.6% Sep 30, 2021
Q2 2021 869 -101 -10.4% Jun 30, 2021
Q1 2021 881 -87.4 -9.03% Mar 31, 2021
Q4 2020 893 +96.8 +12.2% Dec 31, 2020
Q3 2020 944 +243 +34.7% Sep 30, 2020
Q2 2020 970 Jun 30, 2020
Q1 2020 968 Mar 31, 2020
Q4 2019 796 Dec 31, 2019
Q3 2019 701 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.